Showing results (2721-2730 of 9,180) with videos related to
Sort By:
Pageof 918
Cancer Medicine|September 7, 2023
Integrating bioinformatic analysis and detailed experiments reveal an EMT-related biomarker for clear cell renal cell carcinomaYue Ge, Sheng Ma, Junbiao Zhang, et al.Cancer Medicine|August 29, 2023
Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit studySatoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.Cancer Medicine|August 8, 2023
Guanylate-binding proteins signature predicts favorable prognosis, immune-hot microenvironment, and immunotherapy response in hepatocellular carcinomaYumei Ning, Shilin Fang, Jun Fang, et al.Cancer Medicine|August 10, 2023
Tools to assess employment readiness for colorectal cancer survivors: A scoping reviewMingshuang Ding, Elise Gane, Harry Wiffen, et al.Cancer Medicine|August 7, 2023
Benefits and harms of breast cancer screening: Cohort study of breast cancer mortality and overdiagnosisSabrina Wang, Farhana Sultana, Anne Kavanagh, et al.Cancer Medicine|August 9, 2023
Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemiaMay Garrett, Beverly Knight, Jorge E Cortes, et al.Cancer Medicine|August 8, 2023
β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanomaCornelia Schuster, Lars A Akslen, Oddbjørn StraumeCancer Medicine|August 10, 2023
Physical exercise recommendations for patients with polycythemia vera based on preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)Sabine Felser, Julia Rogahn, Lina Hollenbach, et al.Cancer Medicine|August 4, 2023
Quantifying mortality burden in patients with cancer due to COVID-19 in the US: A national cross-sectional analysisBhaghyasree Jambunathan, Jacob Lang, Malik Mays, et al.Cancer Medicine|August 4, 2023
Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapyLaurent Zelek, Rudolph Navari, Matti Aapro, et al.Pageof 918